Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Clinical Nephrology
|
April 17, 1998
Co-trimoxazole-induced hypouricemia
E Liberopoulos, M S Elisaf
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 3, 2002
Marked hyperphosphataemia in a patient with diabetic ketoacidosis
E Liberopoulos, D Christidis, M Elisaf
Clinical Biochemistry
|
June 2, 2001
The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype
E Liberopoulos, N Pavlidis, M Elisaf
Diabetes, Obesity & Metabolism
|
April 12, 2001
Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism
E Liberopoulos, G Miltiadous, M Elisaf
Current Pharmaceutical Design
|
February 10, 2009
Pleiotropic effects of fenofibrate
V Tsimihodimos, E Liberopoulos, M Elisaf
International Angiology : a Journal of the International Union of Angiology
|
July 13, 2011
Anticoagulant drugs: what is new?
A Kei, M Florentin, M Elisaf, et al.
The Journal of Infection
|
January 15, 2004
Enterococcus casseliflavus bacteremia. Case report and literature review
G Pappas, E Liberopoulos, E Tsianos, et al.
International Urology and Nephrology
|
January 14, 2017
PCSK9 in chronic kidney disease
P Pavlakou, E Liberopoulos, E Dounousi, et al.
Nephron
|
November 27, 2001
Mechanisms of hypocalcemia in alcoholic patients
M Elisaf, G Liamis, E Liberopoulos, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 13, 1999
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic
V Tsimihodimos, E Bairaktari, C Tzallas, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Clinical Nephrology
|
April 17, 1998
Co-trimoxazole-induced hypouricemia
E Liberopoulos, M S Elisaf
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 3, 2002
Marked hyperphosphataemia in a patient with diabetic ketoacidosis
E Liberopoulos, D Christidis, M Elisaf
Clinical Biochemistry
|
June 2, 2001
The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype
E Liberopoulos, N Pavlidis, M Elisaf
Diabetes, Obesity & Metabolism
|
April 12, 2001
Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism
E Liberopoulos, G Miltiadous, M Elisaf
Current Pharmaceutical Design
|
February 10, 2009
Pleiotropic effects of fenofibrate
V Tsimihodimos, E Liberopoulos, M Elisaf
International Angiology : a Journal of the International Union of Angiology
|
July 13, 2011
Anticoagulant drugs: what is new?
A Kei, M Florentin, M Elisaf, et al.
The Journal of Infection
|
January 15, 2004
Enterococcus casseliflavus bacteremia. Case report and literature review
G Pappas, E Liberopoulos, E Tsianos, et al.
International Urology and Nephrology
|
January 14, 2017
PCSK9 in chronic kidney disease
P Pavlakou, E Liberopoulos, E Dounousi, et al.
Nephron
|
November 27, 2001
Mechanisms of hypocalcemia in alcoholic patients
M Elisaf, G Liamis, E Liberopoulos, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 13, 1999
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic
V Tsimihodimos, E Bairaktari, C Tzallas, et al.
Page
of 2